Overview
Crouzon syndrome, also known as craniofacial dysostosis type I or Crouzon craniofacial dysostosis, is a genetic disorder characterized by the premature fusion of certain skull bones (craniosynostosis). This early fusion prevents the skull from growing normally and affects the shape of the head and face. It is one of the most common craniosynostosis syndromes and is caused by mutations in the FGFR2 (fibroblast growth factor receptor 2) gene on chromosome 10. Approximately 30–60% of cases arise from de novo (new) mutations, with the remainder inherited from an affected parent. The hallmark features of Crouzon syndrome involve the craniofacial skeleton. Premature fusion of the coronal and sometimes other cranial sutures leads to brachycephaly (short, broad skull) or other abnormal head shapes. Midface hypoplasia (underdevelopment of the middle portion of the face) results in shallow orbits with proptosis (bulging eyes), a beaked nose, and relative mandibular prognathism (prominent lower jaw). Patients frequently experience dental malocclusion and a high-arched or cleft palate. Ocular complications include exposure keratitis due to proptosis, strabismus, and occasionally optic nerve compression leading to vision loss. Conductive hearing loss occurs in a significant proportion of patients due to middle ear anomalies or external auditory canal atresia. Elevated intracranial pressure is a serious concern and can develop due to restricted skull growth, potentially causing headaches, papilledema, and cognitive impairment if untreated. Importantly, intelligence is typically normal in Crouzon syndrome, though developmental delays can occur if raised intracranial pressure is not managed. Treatment of Crouzon syndrome is primarily surgical and requires a multidisciplinary approach involving craniofacial surgeons, neurosurgeons, ophthalmologists, otolaryngologists, orthodontists, and speech therapists. Early cranial vault remodeling surgery may be necessary to relieve intracranial pressure and reshape the skull. Midface advancement procedures, such as Le Fort III osteotomy or distraction osteogenesis, are often performed during childhood or adolescence to correct midface hypoplasia, improve airway patency, and protect the eyes. Obstructive sleep apnea is common and may require intervention including adenotonsillectomy, CPAP, or tracheostomy in severe cases. Hearing aids or surgical correction may be needed for hearing loss. Long-term follow-up is essential, as multiple staged surgeries are typically required throughout growth and development.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
2 eventsSameek Roychowdhury — PHASE2
Cogent Biosciences, Inc. — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Crouzon syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Crouzon syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Crouzon syndrome.
Community
No community posts yet. Be the first to share your experience with Crouzon syndrome.
Start the conversation →Latest news about Crouzon syndrome
Disease timeline:
New recruiting trial: A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy
A new clinical trial is recruiting patients for Crouzon syndrome
New recruiting trial: A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors
A new clinical trial is recruiting patients for Crouzon syndrome
New recruiting trial: A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
A new clinical trial is recruiting patients for Crouzon syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Crouzon syndrome
What is Crouzon syndrome?
Crouzon syndrome, also known as craniofacial dysostosis type I or Crouzon craniofacial dysostosis, is a genetic disorder characterized by the premature fusion of certain skull bones (craniosynostosis). This early fusion prevents the skull from growing normally and affects the shape of the head and face. It is one of the most common craniosynostosis syndromes and is caused by mutations in the FGFR2 (fibroblast growth factor receptor 2) gene on chromosome 10. Approximately 30–60% of cases arise from de novo (new) mutations, with the remainder inherited from an affected parent. The hallmark feat
How is Crouzon syndrome inherited?
Crouzon syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Crouzon syndrome typically begin?
Typical onset of Crouzon syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Crouzon syndrome?
19 specialists and care centers treating Crouzon syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.